These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3908219)

  • 21. A comparison of avian and rodent S-9 liver homogenates in the Ames test.
    Rosanoff KA; Jones DH; Sawyer TW
    Res Commun Chem Pathol Pharmacol; 1984 Apr; 44(1):131-9. PubMed ID: 6328598
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutagenicity studies in Salmonella typhimurium on some carcinogenic N-nitramines in vitro and in the host-mediated assay in rats.
    Khudoley V; Malaveille C; Bartsch H
    Cancer Res; 1981 Aug; 41(8):3205-10. PubMed ID: 7018677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The pH-dependent response of Salmonella typhimurium TA100 to mutagenic N-nitrosamines.
    Negishi T; Hayatsu H
    Mutat Res; 1980 Nov; 79(3):223-30. PubMed ID: 7012604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alcoholdehydrogenase as an activating enzyme for N-nitrosodiethanolamine (NDELA): in vitro activation of NDELA to a potent mutagen in Salmonella typhimurium.
    Eisenbrand G; Denkel E; Pool B
    J Cancer Res Clin Oncol; 1984; 108(1):76-80. PubMed ID: 6378917
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro biotransformation and genotoxicity of the drinking water disinfection byproduct bromodichloromethane: DNA binding mediated by glutathione transferase theta 1-1.
    Ross MK; Pegram RA
    Toxicol Appl Pharmacol; 2004 Mar; 195(2):166-81. PubMed ID: 14998683
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Study of the mutagenic action of cyclophosphane on bacteria in host-mediated assay.
    Shapiro AA; Fonshtein LM
    Biol Bull Acad Sci USSR; 1979; 6(3):310-5. PubMed ID: 399196
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased mutagenicity of chloroethylnitrosoureas in the presence of a rat liver S9 microsome mixture.
    Suling WJ; Rice LS; Shannon WM
    J Natl Cancer Inst; 1983 Apr; 70(4):767-9. PubMed ID: 6220173
    [TBL] [Abstract][Full Text] [Related]  

  • 28. N-Nitroso-2-hydroxymorpholine, a mutagenic metabolite of N-nitrosodiethanolamine.
    Hecht SS
    Carcinogenesis; 1984 Dec; 5(12):1745-7. PubMed ID: 6499128
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Greater effectiveness of hepatocyte and liver S9 preparations from hamsters than rat preparations in activating N-nitroso compounds to metabolites mutagenic to Salmonella.
    Raineri R; Poiley JA; Andrews AW; Pienta RJ; Lijinsky W
    J Natl Cancer Inst; 1981 Nov; 67(5):1117-22. PubMed ID: 6946249
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sulfate esters of hydroxymethyl-methyl-benz[a]anthracenes as active metabolites of 7,12-dimethylbenz[a]anthracene.
    Watabe T; Ishizuka T; Fujieda T; Hiratsuka A; Ogura K
    Jpn J Cancer Res; 1985 Aug; 76(8):684-98. PubMed ID: 3930446
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Metabolic activation of promutagens in the yeast-microsome test. II. Activation of cyclophosphamide and 2-aminofluorene].
    Pavlov IuI; Khromov-Borisov NN
    Genetika; 1983 Mar; 19(3):362-74. PubMed ID: 6343182
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Histochemical demonstration of enhanced glutathione content in enzyme-altered islands induced by carcinogens in rat liver.
    Deml E; Oesterle D
    Cancer Res; 1980 Feb; 40(2):490-1. PubMed ID: 6101309
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutagenicity of N-nitroso compounds formed by the reaction of sulpyrine with nitrite; effects of cysteine and its derivatives.
    Sakai A; Tanimura A
    IARC Sci Publ; 1982; (41):709-17. PubMed ID: 6982852
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Standardization of conditions for the metabolic activation of N-nitrosodiethylamine in mutagenicity tests.
    Aiub CA; Pinto LF; Felzenszwalb I
    Genet Mol Res; 2004 Jun; 3(2):264-72. PubMed ID: 15266397
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An evaluation of the mode of action framework for mutagenic carcinogens case study: Cyclophosphamide.
    McCarroll N; Keshava N; Cimino M; Chu M; Dearfield K; Keshava C; Kligerman A; Owen R; Protzel A; Putzrath R; Schoeny R
    Environ Mol Mutagen; 2008 Mar; 49(2):117-31. PubMed ID: 18240158
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The role of metabolic activation of promutagens in the genome destabilization under pheromonal stress in the house mouse (Mus musculus)].
    Zhuk AS; Stepchenkova EI; Dukel'skaia AV; Daev EV; Inge-Vechtomov SG
    Genetika; 2011 Oct; 47(10):1357-63. PubMed ID: 22232923
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutagenicity of tetrachloroethene in the Ames test--metabolic activation by conjugation with glutathione.
    Vamvakas S; Herkenhoff M; Dekant W; Henschler D
    J Biochem Toxicol; 1989; 4(1):21-7. PubMed ID: 2671372
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of rat/hamster S-9 mixture in the Ames mutagenicity assay.
    Weinstein D; Katz M; Kazmer S
    Environ Mutagen; 1981; 3(1):1-9. PubMed ID: 7021141
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutagenicity and synthesis of alpha-substituted N-nitrosamines: derivatives with dithiocarbamic acid.
    Pool BL; Bertram B; Wiessler M
    Carcinogenesis; 1982; 3(5):563-7. PubMed ID: 7046980
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reaction of nitrosamines in the Udenfriend system: principal products and biological activity.
    Hsieh ST; Kraft PL; Archer MC; Tannenbaum SR
    Mutat Res; 1976 Apr; 35(1):23-8. PubMed ID: 775321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.